Primary cultures of rat cerebellar granule cells as a model to study neuronal 5-lipoxygenase and FLAP gene expression

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 183-190

  Manev, Hari ^a   Tolga, Uz ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CORTICOSTERONE; CYTARABINE; DEXAMETHASONE; EXCITOTOXIN; GLUCOCORTICOID; LEUKOTRIENE; LIPOXYGENASE INHIBITOR; MELATONIN; NEUROPROTECTIVE AGENT; PINEAL BODY HORMONE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; BRAIN INJURY; CELL MATURATION; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENCEPHALITIS; ENZYME BLOOD LEVEL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULE CELL; HORMONE RELEASE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PINEALECTOMY; RAT; STEROID RELEASE;

ANIMALIA; SIGANUS;

EID: 0033392866     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07994.x     Document Type: Conference Paper

References (23)

1. 1. Maccarrone, M., M. Navarra, M.T. Corasanti, G. Nistico & A. Finazzi Agro. 1998. Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of arachidonate cascade. Biochem. J. 333: 45-49.
2. 2. Breitner, J.C.S. 1996. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging 17: 789-794.
3. 3. Nakayama, M., K. Uchimura, R.L. Zhu, T. Nagayama, M.E. Rose, R.A. Stetler, P.C. Isakson & S.H. Graham. 1998. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. USA 95: 10954-10959.
4. 4. Lammers, C.-H., P. Schweitzer, P. Facchinetti, J.-M. Arrang, S.G. Madamba, G.R. Siggins & D. Piomelli. 1996. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J. Neurochem. 66: 147-152.
5. 5. Drazen, J. 1998. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am. J. Respir. Crit. Care Med. 157: S233-S237.
6. 6. Hoshiko, S., O. Radmar & B. Samuelsson. 1990. Characterization of the human 5-lipoxygenase gene promoter. Proc. Natl. Acad. Sci. USA 87: 9073-9077.
7. 7. Wiesenberg, I., M. Missbach & C. Carlberg. 1998. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor. Neurol. Neurosci. 12: 143-150.
8. 8. Riddick, C.A., W.L. Ring, J.R. Baker, C.R. Hodulik & T.D. Bigby. 1997. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur. J. Biochem. 246: 112-118.
9. 9. Uz, T., C. Pesold, P. Longone & H. Manev. 1998. Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J. 12: 439-449.
10. 10. Manev, H., T. Uz & T. Qu. 1998. Early upregulation of hippocampal 5-lipoxygenase following systemic administration of kainate to rats. Restor. Neurol. Neurosci. 12: 81-85.
11. 11. Peter-Golden, M. 1998. Cell biology of the 5-lipoxygenase pathway. Am. J. Respir. Crit. Care Med. 157: S227-S232.
12. 12. Lepley, R.A. & F.A. Fitzpatrick. 1994. 5-Lipoxygenase contains a functional src homology 3-binding motif that interacts with the src homology 3 domain of Grb2 and cytoskeletal proteins. J. Biol. Chem. 269: 24163-24168.
13. 13. Lepley, R.A. & F.A. Fitzpatrick. 1998. 5-Lipoxygenase compartmentalization in granulocytic cells is modulated by an internal bipartite nuclear localizing sequence and nuclear factor κB complex formation. Arch. Biochem. Biophys. 356: 71-76.
14. 14. Steinhilber, D., M. Brungs, O. Werz, I. Wiesenberg, C. Danielsson, J.-P. Kahlen, S. Nayeri, M. Schräder & C. Carlberg. 1995. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes J. Biol. Chem. 270: 7037-7040.
15. 15. Silverman, E.S., J. Du, A.J. Williams, R. Wadgaonkar, J.M. drazen & T. Collins. 1998. Camp-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1). Biochem. J. 336: 183-189.
16. 16. In, K.H., K. Asano, D. beier, J. Grobholz, P.W. Finn, E.K. Silverman, E.S. Silverman, T. Collins, A.R. Fischer, T.P. Keith, K. Serino, S.W. Kim, G.T. Desanctis, C. Yandava, A. Pillari, P. Rubin, J. Kemp, E. Israel, W. Busse, D. Ledford, J.J. Murray, A. Segal, D. Tinkleman & J.M. Drazen. 1997. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99: 1130-1137.
17. 17. Manev, H., M. Favaron, A. Guidotti & E. Costa. 1989. Delayed increase of calcium influx elicited by glutamate: role in neuronal death. Mol. Pharmacol. 36: 106-112.
18. 18. Uz, T., P. Longone & H. Manev. 1997. Increased hippocampal 5-lipoxygenase mRNA content in melatonin-deficient, pinealectomized rats. J. Neurochem. 69: 2220-2223.
19. 19. Dixon, R.A.F., R.E. Diehl, E. Opas, E. Rands, P.J. Vickers, J.F. Evans, J.W. Gillard & O.K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343: 282-284.
20. 3, retinoic acid, DMSO and TGF beta. Biochem. Biophys. Res. Commun. 205: 1572-1580.
21. 21. Brewer, G.J. 1995. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42: 674-683.
22. 22. Ohtsuki, T., M. Matsumoto, Y. Hayashi, K. Yamamoto, K. kitagawa, S. Ogawa, S. Yamamoto & T. kamada. 1995. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am. J. Physiol. 268: H1249-H1257.
23. 23. Lepley, R.A., D.T. Muskardin & F.A. Fitzpatrick. 1996. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271: 6179-6184.